UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

Nature communications, 2022-07, Vol.13 (1), p.3840-3840, Article 3840

2022

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Vaccine, 2021-05, Vol.39 (22), p.3053-3066

2021

Link zum Volltext

Verfügbarkeit prüfen

Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity

Cell reports (Cambridge), 2021-10, Vol.37 (1), p.109773-109773, Article 109773

2021

Link zum Volltext

Verfügbarkeit prüfen

Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab

JAMA neurology, 2022-04, Vol.79 (4), p.399

2022

Link zum Volltext

Verfügbarkeit prüfen

Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults

Vaccine, 2022-04, Vol.40 (19), p.2714-2722

2022

Link zum Volltext

Verfügbarkeit prüfen

Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

Vaccine, 2020-06, Vol.38 (31), p.4783-4791

2020

Link zum Volltext

Verfügbarkeit prüfen

Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine

The Journal of infectious diseases, 2022-11, Vol.226 (11), p.1943-1948

2022

Link zum Volltext

Verfügbarkeit prüfen

Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design

npj vaccines, 2023-03, Vol.8 (1), p.34-34, Article 34

2023

Link zum Volltext

Verfügbarkeit prüfen

Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention

Vaccines (Basel), 2021-09, Vol.9 (9), p.1002

2021

Link zum Volltext

Verfügbarkeit prüfen

Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children: The potential role of prior natural infection

Pediatric allergy and immunology, 2024-05, Vol.35 (5), p.e14161-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

npj vaccines, 2021-05, Vol.6 (1), p.78-78, Article 78

2021

Link zum Volltext

Verfügbarkeit prüfen

Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor

Vaccine, 2012-10, Vol.30 (45), p.6359-6367

2012

Link zum Volltext

Verfügbarkeit prüfen

Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2011-08, Vol.25 (4), p.217-226

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 14 von 14

Suche als RSS-Feed

Aktive Filter

ThemaAntibodies

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Vaccines
(12)
Humans
(9)
Immunology
(9)
Medicine, Research & Experimental
(7)
Research & Experimental Medicine
(7)
Infections
(6)
Severe Acute Respiratory Syndrome Coronavirus 2
(6)
Antigens
(5)
Covid-19
(5)
Immunization
(5)
Sars-Cov-2
(5)
Coronaviruses
(4)
Covid-19 Vaccines
(4)
Immune System
(4)
Infectious Diseases
(4)
Proteins
(4)
Severe Acute Respiratory Syndrome
(4)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity

Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab

Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults

Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine

Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design

Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol

Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention

Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children: The potential role of prior natural infection

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor

Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach

Aktive Filter

Suchergebnisse filtern